The New England Journal of Medicine Claims Post Surgery Drug Therapy Increases Lung Cancer 5-Year Survival Rate to 88%
Read about the study that shows Osimertinib can help increase 5-year post-surgery survival rate for patients with Non-Small Cell Lung Cancel. AUSTIN, TEXAS, UNITED STATES, October 2, 2023 /EINPresswire.com/ -- While overall cancer survival rates have …